Stephanie C. Eisenbarth

Stephanie C. Eisenbarth

Auto-generated profile, based on publicly available information

Stephanie C. Eisenbarth

The Department Medicine, Division of Allergy and Immunology Northwestern University Feinberg School of Medicine Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2014 in Nature
Verified
Journal Article
Closed access
PDF file
OCOscar R. Colegio
Oscar R. Colegio
NCNgoc-Quynh Chu
Ngoc-Quynh Chu
ASAlison L. Szabo
Alison L. Szabo
TCThach Chu
Thach Chu
ARAnne Marie Rhebergen
Anne Marie Rhebergen
RMRuslan Medzhitov
Ruslan Medzhitov

1 February 2012 in Nature
Verified
Journal Article
Open access
PDF file
JHJorge Henao-Mejia
Jorge Henao-Mejia
Eran ElinavEran Elinav
Eran Elinav
CJChengcheng Jin
Chengcheng Jin
LHLiming Hao
Liming Hao
WMWajahat Z. Mehal
Wajahat Z. Mehal
RFRichard A. Flavell
Richard A. Flavell
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty per cent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis, portal hypertension and hepatocellular carcinoma, yet the causes of progression from NAFLD to NASH remain obscure. Here, we show that the NLRP6 and NLRP3 inflammasomes and the effector protein IL-18 negatively regulate NAFLD/NASH progression, as well as multiple aspects of metabolic syndrome via modulation of the gut microbiota. Different mouse models reveal that inflammasome-deficiency-associated changes in the configuration of the gut microbiota are associated with exacerbated hepatic steatosis and inflammation through influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-necrosis factor (TNF)-α expression that drives NASH progression. Furthermore, co-housing of inflammasome-deficient mice with wild-type mice results in exacerbation of hepatic steatosis and obesity. Thus, altered interactions between the gut microbiota and the host, produced by defective NLRP3 and NLRP6 inflammasome sensing, may govern the rate of progression of multiple metabolic syndrome-associated abnormalities, highlighting the central role of the microbiota in the pathogenesis of heretofore seemingly unrelated systemic auto-inflammatory and metabolic disorders.

1 May 2011 in Cell
Verified
Journal Article
Closed access
Eran ElinavEran Elinav
Eran Elinav
TSTill Strowig
Till Strowig
AKAndrew L. Kau
Andrew L. Kau
JHJorge Henao-Mejia
Jorge Henao-Mejia
CTChristoph A. Thaiss
Christoph A. Thaiss
RFRichard A. Flavell
Richard A. Flavell

21 May 2008 in Nature
Verified
Journal Article
Closed access
PDF file
SEStephanie C. Eisenbarth
Stephanie C. Eisenbarth
OCOscar R. Colegio
Oscar R. Colegio
WOWilliam O’connor
William O’connor
FSFayyaz S. Sutterwala
Fayyaz S. Sutterwala
RFRichard A. Flavell
Richard A. Flavell

22 March 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
SLSteven M. Lewis
Steven M. Lewis
AWAdam Williams
Adam Williams
SEStephanie C. Eisenbarth
Stephanie C. Eisenbarth
The spleen is a multitasking secondary lymphoid organ with specialized cells for initiating immunity to blood-borne targets.

16 December 2002 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SEStephanie C. Eisenbarth
Stephanie C. Eisenbarth
DPDamani A. Piggott
Damani A. Piggott
JHJames W. Huleatt
James W. Huleatt
IVIrene Visintin
Irene Visintin
CHChristina A. Herrick
Christina A. Herrick
KBKim Bottomly
Kim Bottomly
Allergic asthma is an inflammatory lung disease initiated and directed by T helper cells type 2 (Th2). The mechanism involved in generation of Th2 responses to inert inhaled antigens, however, is unknown. Epidemiological evidence suggests that exposure to lipopolysaccharide (LPS) or other microbial products can influence the development and severity of asthma. However, the mechanism by which LPS influences asthma pathogenesis remains undefined. Although it is known that signaling through Toll-like receptors (TLR) is required for adaptive T helper cell type 1 (Th1) responses, it is unclear if TLRs are needed for Th2 priming. Here, we report that low level inhaled LPS signaling through TLR4 is necessary to induce Th2 responses to inhaled antigens in a mouse model of allergic sensitization. The mechanism by which LPS signaling results in Th2 sensitization involves the activation of antigen-containing dendritic cells. In contrast to low levels, inhalation of high levels of LPS with antigen results in Th1 responses. These studies suggest that the level of LPS exposure can determine the type of inflammatory response generated and provide a potential mechanistic explanation of epidemiological data on endotoxin exposure and asthma prevalence.